Minerva Neurosciences Inc (NERV)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $114.62M
Last updated: Nov 17, 2026 at 11:06 AM ET
Minerva Neurosciences Inc (NERV) Competitors
The companies most similar to Minerva Neurosciences are Neumora Therapeutics (NMRA), NRX Pharmaceuticals (NRXP) and LENZ Therapeutics (LENZ). By market cap, Minerva Neurosciences ranks 7th of the 13 companies on this page; Zentalis Pharmaceuticals Llc (ZNTL) is the largest at $167.05M.
Peer Comparison
NERV's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Minerva Neurosciences (NERV) | $114.62M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Neumora Therapeutics, Inc. (NMRA) | $80.59M | N/A | N/A | 0.0% | -260.5% | 0.0% | 0.00% |
| NRX Pharmaceuticals Inc (NRXP) | $95.58M | N/A | 23.8x | 0.0% | N/A | 0.0% | 0.00% |
| LENZ Therapeutics Inc (LENZ) | $129.77M | N/A | 9.7x | 0.0% | N/A | -72.9% | 0.00% |
| Voyager Therapeutics Inc (VYGR) | $107.66M | N/A | 4.0x | 0.0% | N/A | -70.0% | 0.00% |
| Neuraxis, Inc. (NRXS) | $76.93M | N/A | 9.6x | -144.4% | -247.7% | 115.7% | 0.00% |
| Immunic Inc (IMUX) | $102.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Sionna Therapeutics, Inc. Common Stock (SION) | $150.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Pmv Pharmaceuticals Inc (PMVP) | $95.93M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | $141.66M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Compass Therapeutics Inc. (CMPX) | $139.35M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Zentalis Pharmaceuticals Llc (ZNTL) | $167.05M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cassava Sciences Inc (SAVA) | $114.97M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $111.31M | N/A | 9.7x | 0.0% | -254.1% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Minerva Neurosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases... | NMRA competitors |
| NRX Pharmaceuticals Inc (NRXP) | NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company... | NRXP competitors |
| LENZ Therapeutics Inc (LENZ) | LENZ Therapeutics Inc is a cutting-edge biopharmaceutical company dedicated to developing transformative therapies for neurological disorders... | LENZ competitors |
| Voyager Therapeutics Inc (VYGR) | Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. | VYGR competitors |
| Neuraxis, Inc. (NRXS) | NeurAxis, Inc. is a neuromodulation therapy device company in the United States. The company is headquartered in Versailles, Indiana. | NRXS competitors |
| Immunic Inc (IMUX) | Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune... | IMUX competitors |
| Sionna Therapeutics, Inc. Common Stock (SION) | Sionna Therapeutics, Inc. is an innovative biotechnology company focused on developing advanced therapies for neurodegenerative disorders... | SION competitors |
| Pmv Pharmaceuticals Inc (PMVP) | PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53... | PMVP competitors |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy... | NTHI competitors |
| Compass Therapeutics Inc. (CMPX) | Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple... | CMPX competitors |
| Zentalis Pharmaceuticals Llc (ZNTL) | Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment... | ZNTL competitors |
| Cassava Sciences Inc (SAVA) | Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas. |
Frequently Asked Questions About NERV
Who are Minerva Neurosciences' main competitors?
The companies most similar to Minerva Neurosciences include Neumora Therapeutics (NMRA), NRX Pharmaceuticals (NRXP), LENZ Therapeutics (LENZ), Voyager Therapeutics (VYGR) and Neuraxis (NRXS), listed from the closest match.
Who is Minerva Neurosciences' biggest competitor?
Zentalis Pharmaceuticals Llc (ZNTL) is the largest of the similar companies at $167.05M; Neumora Therapeutics (NMRA) is the closest match by business profile, size, sector and industry.
How does NERV stock compare with its competitors?
NERV's net margin is 0.0% against a peer median of 0.0%.
Which of Minerva Neurosciences' competitors pays a higher dividend?
Minerva Neurosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Minerva Neurosciences bigger than its competitors?
No. Minerva Neurosciences is 7th by market cap among the 13 companies on this page; the largest is Zentalis Pharmaceuticals Llc (ZNTL) at $167.05M.
NERV pages: Overview, Earnings, Forecast, Financials, Competitors